CVS Caremark to pay $95M in Medicare fraud case A federal judge ruled in favor of a whistleblower, finding CVS’ pharmacy benefit manager Caremark overbilled Medicare for generic drugs.

Medicare is investigating reports that CVS Caremark Corp., the country’s second-largest drugstore chain, has refilled prescriptions and submitted insurance claims without patients’ approval ...

CVS Health's pharmacy benefit manager unit must pay the U.S. government $95 million after a federal judge found it ...

CVS plans to appeal the judgment, which comes after a jury ruled that its long-term care pharmacy benefits manager illegally ...

CVS Health’s pharmacy benefit manager, Caremark, has been ordered to pay $95 million for overbilling Medicare Part D drug reimbursements, a federal judge ruled Wednesday — a decision that ...

An unsealed 2014 lawsuit by an Aetna actuary whistleblower against CVS Caremark, the insurer's pharmacy benefit manager, accuses the PBM of billing the government for prescription drugs at a greater ...

Pharmacy benefit manager CVS Caremark drops Zepbound coverage, estimating 10-15% savings while Eli Lilly offers self-pay ...

A huge whistleblower lawsuit has been filed against CVS Caremark, ... the fraud could impact many more. ... which happens to be one of the largest Medicare Drug clients of CVS Caremark.

CVS must pay the government at least $95 million after a federal court ruled in favor of a whistleblower, finding its pharmacy benefit subsidiary Caremark overcharged Medicare for generic drugs.

CVS Caremark to pay $95M in Medicare fraud case. Sydney Halleman . Thu, Jun 26, 2025, 5:16 AM 2 min read. In This Article: CVS . This story was originally published on Healthcare Dive.